Cargando…
Imaging of multidrug resistance in cancer
Primary intrinsic and/or acquired multidrug resistance (MDR) is the main obstacle to successful cancer treatment. Functional molecular imaging of MDR in cancer using single photon or positron emitters may be helpful to identify multidrug-resistant tumours and predict not only those patients who are...
Autores principales: | Dizdarevic, S., Peters, A.M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
e-Med
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3080121/ https://www.ncbi.nlm.nih.gov/pubmed/21362586 http://dx.doi.org/10.1102/1470-7330.2011.0001 |
Ejemplares similares
-
In vivo characterization of [(18)F]AVT-011 as a radiotracer for PET imaging of multidrug resistance
por: Kannan, Pavitra, et al.
Publicado: (2019) -
Multidrug resistance associated proteins in multidrug resistance
por: Sodani, Kamlesh, et al.
Publicado: (2012) -
Autophagy and multidrug resistance in cancer
por: Li, Ying-Jie, et al.
Publicado: (2017) -
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
por: Bukowski, Karol, et al.
Publicado: (2020) -
Multidrug-resistant breast cancer: current perspectives
por: Martin, Heather L, et al.
Publicado: (2014)